Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

JANXJANX
Showing 8 of 9 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in JANUX THERAPEUTICS INC

Point72 Asset Management, L.P. holds 2M shares of JANX (JANUX THERAPEUTICS INC), worth $30.6M as of 2026-Q2. The position was increased (+72.5% shares). JANX represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$30.6M

Current Shares

2M

Total Value Change

+$12.6M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+72.5%
$30.6M0.0%$15.36
43
2026-Q1
Increased
1.2M
+20.2%
$16.1M0.0%$13.44
34
2025-Q4
Decreased
961,819
-43.8%
$13.3M0.0%$13.83
0
2025-Q3
Decreased
1.7M
-20.2%
$41.8M0.1%$23.70
0
2025-Q2
Increased
2.1M
+469.2%
$49.5M0.1%$23.15
47
2025-Q1
Decreased
376,662
-39.4%
$10.2M0.0%$29.10
0
2024-Q4
Increased
621,383
+57.0%
$33.3M0.1%$52.50
41
2024-Q3
Increased
395,875
+190.2%
$18M0.0%$46.25
46

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used